Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lourdes Ruiz-Ortega

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 1, 2025
JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a SummerJuan Carlos Ruiz-Cobo, Lourdes Ruiz-Ortega, Virginia Robles-Alonso, et al.
Hepatology Communications|October 11, 2024
Zinc supplementation to improve prognosis in patients with compensated advanced chronic liver disease: a multicenter, randomized, double-blind, placebo-controlled clinical trialJuan Bañares, Laia Aceituno, Lourdes Ruiz-Ortega, et al.
Frontiers in Endocrinology|September 12, 2022
Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control studyJuan Bañares, Ramiro Manzano-Nuñez, Alba Prió, et al.
Frontiers in Medicine|August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening RateLaia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
Journal for Immunotherapy of Cancer|March 27, 2026
Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuriesStuart Astbury, Edmond Atallah, Jane I Grove, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Liver International : Official Journal of the International Association for the Study of the Liver|January 1, 2025
JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a SummerJuan Carlos Ruiz-Cobo, Lourdes Ruiz-Ortega, Virginia Robles-Alonso, et al.
Hepatology Communications|October 11, 2024
Zinc supplementation to improve prognosis in patients with compensated advanced chronic liver disease: a multicenter, randomized, double-blind, placebo-controlled clinical trialJuan Bañares, Laia Aceituno, Lourdes Ruiz-Ortega, et al.
Frontiers in Endocrinology|September 12, 2022
Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control studyJuan Bañares, Ramiro Manzano-Nuñez, Alba Prió, et al.
Frontiers in Medicine|August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening RateLaia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
Journal for Immunotherapy of Cancer|March 27, 2026
Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuriesStuart Astbury, Edmond Atallah, Jane I Grove, et al.
Pageof 1